Stock listing

Corvus Pharmaceuticals, Inc.

Selected listing: CRVS · NASDAQ · USD · US

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), Health Technology. Latest release Sep 30, 2026: Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical…

CRVS:NASDAQUSDUSUpdated October 9, 2026
Corvus Pharmaceuticals, Inc. logo
Ticker
NASDAQ:CRVS
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

About Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. (Ticker: CRVS) is a publicly traded company based in the United States, focusing on the development of innovative therapies for cancer treatment. The company is committed to addressing unmet medical needs through its unique approach to drug development.

Latest news from Corvus Pharmaceuticals, Inc.

All Corvus Pharmaceuticals, Inc. news →

Events

Replays

  • Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 04:30 PM ET

    Watch
  • Corvus Pharmaceuticals, Inc. (CRVS) Q4 2025 Earnings Call

    Thu, Mar 12, 2026 · 04:30 PM ET

    Watch
  • Corvus Pharmaceuticals, Inc. (CRVS) Q3 2025 Earnings Call

    Tue, Nov 04, 2025 · 04:30 PM ET

    Watch

Research Corvus Pharmaceuticals, Inc.

Alternate listings